Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
2.780
+0.010 (0.36%)
Nov 21, 2024, 1:20 PM EST - Market open

Trevi Therapeutics Statistics

Total Valuation

TRVI has a market cap or net worth of $213.69 million. The enterprise value is $148.54 million.

Market Cap 213.69M
Enterprise Value 148.54M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date Nov 6, 2024
Ex-Dividend Date n/a

Share Statistics

TRVI has 76.87 million shares outstanding. The number of shares has increased by 1.57% in one year.

Current Share Class 76.87M
Shares Outstanding 76.87M
Shares Change (YoY) +1.57%
Shares Change (QoQ) +0.24%
Owned by Insiders (%) 1.19%
Owned by Institutions (%) 39.02%
Float 47.77M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.54
P/TBV Ratio 3.69
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.02.

Current Ratio 7.38
Quick Ratio 7.21
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -6,887.71

Financial Efficiency

Return on equity (ROE) is -59.65% and return on invested capital (ROIC) is -39.89%.

Return on Equity (ROE) -59.65%
Return on Assets (ROA) -36.57%
Return on Capital (ROIC) -39.89%
Revenue Per Employee n/a
Profits Per Employee -$1.77M
Employee Count 25
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -28,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +99.28% in the last 52 weeks. The beta is 1.01, so TRVI's price volatility has been similar to the market average.

Beta (5Y) 1.01
52-Week Price Change +99.28%
50-Day Moving Average 3.12
200-Day Moving Average 2.90
Relative Strength Index (RSI) 41.52
Average Volume (20 Days) 523,249

Short Selling Information

The latest short interest is 1.72 million, so 2.23% of the outstanding shares have been sold short.

Short Interest 1.72M
Short Previous Month 1.52M
Short % of Shares Out 2.23%
Short % of Float 3.59%
Short Ratio (days to cover) 3.78

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -48.21M
Pretax Income -38.78M
Net Income -44.32M
EBITDA -48.07M
EBIT -48.21M
Earnings Per Share (EPS) -$0.44
Full Income Statement

Balance Sheet

The company has $65.49 million in cash and $1.11 million in debt, giving a net cash position of $64.38 million or $0.84 per share.

Cash & Cash Equivalents 65.49M
Total Debt 1.11M
Net Cash 64.38M
Net Cash Per Share $0.84
Equity (Book Value) 58.97M
Book Value Per Share 0.78
Working Capital 58.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.07 million and capital expenditures -$50,000, giving a free cash flow of -$35.12 million.

Operating Cash Flow -35.07M
Capital Expenditures -50,000
Free Cash Flow -35.12M
FCF Per Share -$0.46
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TRVI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.57%
Shareholder Yield -1.57%
Earnings Yield -20.37%
FCF Yield -16.14%

Analyst Forecast

The average price target for TRVI is $9.13, which is 228.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.13
Price Target Difference 228.42%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -11.83%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1